ArticleFire technology2022
Evaluation of Mass Spectrometric Methods for Screening Polycyclic Aromatic Hydrocarbons in the Particulate Phase of Wildfire/Biomass Smoke.
Article in Fire technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Polycyclic aromatic hydrocarbons (PAHs) are a class of compounds containing multiple aromatic rings formed during incomplete combustion. Since many of them are known mutagens and carcinogens, PAHs found in the particulate matter (PM) from the wildfire smoke may pose significant health risks to the wildland firefighters. It is pivotal to determine the levels of PAHs in the PM to evaluate the health effects of their inhalation exposure. However, the determination of PAHs using the conventional chromatographic approaches is often time-consuming and laborious. Herein, we describe a novel method for screening nonpolar and polar PAHs in the PM of smoke by direct analysis in real-time mass spectrometry (DART-MS). PM
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.